GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source Last Updated
PSICQUIC March 30, 2022
Displaying entries 3476 - 3500 of 4050 in total
Antibody ▼ Patient Onset (days) Symptom GlyTouCan ID Arbitrary Fluorescence Units (AFU)
IgA Patient 2 3 mild
G72739GY
390
IgA Patient 2 3 mild
G73271MD
507
IgA Patient 2 3 mild
G75896PD
965
IgA Patient 2 3 mild
G76355TG
538
IgA Patient 2 3 mild
G76615YG
252
IgA Patient 2 3 mild
G77974XY
626
IgA Patient 2 3 mild
G78074HX
241
IgA Patient 2 3 mild
G78255UI
613
IgA Patient 2 3 mild
G80587NA
923
IgA Patient 2 3 mild
G81315DD
1369
IgA Patient 2 3 mild
G82096UQ
440
IgA Patient 2 3 mild
G82204SH
289
IgA Patient 2 3 mild
G82348BZ
340
IgA Patient 2 3 mild
G82779CI
642
IgA Patient 2 3 mild
G82942ZJ
297
IgA Patient 2 3 mild
G84224TW
553
IgA Patient 2 3 mild
G86156UJ
672
IgA Patient 2 3 mild
G86541PE
383
IgA Patient 2 3 mild
G86566MF
374
IgA Patient 2 3 mild
G89993FE
561
IgA Patient 2 3 mild
G90223GH
688
IgA Patient 2 3 mild
G90562PB
285
IgA Patient 2 3 mild
G91237TK
287
IgA Patient 2 3 mild
G91537AT
469
IgA Patient 2 3 mild
G92022ML
745

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024